SCHEMBL4731032

SCHEMBL4731032

CCCCCCCC(C(=O)O)C(O)(C(=O)O)C(CCCCCCC)(CCCCCCC)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.55
BLM P54132 1/20 0.55
HSPE1 P61604 1/20 0.55
MEN1 O00255 1/20 0.50
HPGD P15428 1/20 0.50
RECQL P46063 1/20 0.50
KMT2A Q03164 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GPR84 Q9NQS5 7/20 0.43
FFAR1 O14842 1/20 0.43
MAPT P10636 1/20 0.42
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
ACE2 Q9BYF1 1/20 0.40
GRIK1 P39086 1/20 0.37
GRIK2 Q13002 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14672358 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL4732298 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL1420371 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL101728 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL11213769 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL22187007 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL2486881 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL4731151 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL688124 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL32668942 1.00 HSPD1 (0.55) HSPD1BLMHSPE1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3985056-B1 PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING THE SAME LG CHEMICAL LTD (KR) 2026-03-04 EP claimed
WO-2025224211-A1 SINGLE-COMPONENT SYSTEM FOR COATINGS COVESTRO DEUTSCHLAND AG (DE) 2025-10-30 WO disclosed
WO-2025224257-A1 SINGLE-COMPONENT COATING MATERIAL FOR FOOD CONTAINERS COVESTRO DEUTSCHLAND AG (DE) 2025-10-30 WO disclosed
EP-4640732-A1 ONE-COMPONENT SYSTEM FOR COATINGS Covestro Deutschland AG (DE) 2025-10-29 EP disclosed
EP-4640731-A1 ONE-COMPONENT COATING COMPOSITION FOR FOOD CONTAINERS Covestro Deutschland AG (DE) 2025-10-29 EP disclosed
WO-2025132731-A1 BLOCKED POLYISOCYANATE COVESTRO DEUTSCHLAND AG (DE) 2025-06-26 WO disclosed
EP-4574870-A1 BLOCKED POLYISOCYANATE Covestro Deutschland AG (DE) 2025-06-25 EP disclosed
US-11572453-B2 Plasticizer composition and resin composition including the same LG CHEM, LTD. (KR) 2023-02-07 US disclosed
EP-3327076-B1 PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME LG CHEMICAL LTD (KR) 2022-06-29 EP disclosed
US-20180237613-A1 PLASTICIZER COMPOSITION AND RESIN COMPOSITION INCLUDING THE SAME LG CHEM, LTD. (KR) 2018-08-23 US disclosed
EP-3327076-A1 PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME LG Chem, Ltd. (KR) 2018-05-30 EP disclosed
WO-2008043654-A2 BLOND CLEAR TREATMENT HENKEL AG & CO. KGAA (DE) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572453-B2 Plasticizer composition and resin composition including the same GABRD, TAF5, TERB1 HSPD1 1876/4885BLM 830/4885HSPE1 2814/4885
US-20180237613-A1 PLASTICIZER COMPOSITION AND RESIN COMPOSITION INCLUDING THE SAME LCP1, VCL, VMA21 HSPD1 2588/4885BLM 2299/4885HSPE1 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.